← Leaderboards
Andrew F. Stewart
University Of Pittsburgh At Pittsburgh
$27,613,128
Attributed
$41,359,118
Total exposure
19
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$41,359,118 · 19
By mechanism
R01$29,288,080 · 11
UC4$3,961,165 · 1
U01$3,635,218 · 1
T32$2,591,139 · 1
R33$1,792,299 · 1
M01$56,217 · 3
Top collaborators
- Robert J Devita19 shared
- Adolfo Garcia-Ocana13 shared
- Carmen Argmann5 shared
- Donald K Scott5 shared
- Martin John Walsh5 shared
- Peng Wang5 shared
- Seung K Kim3 shared
- Alvin Carter Powers3 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Guodong Cao$6,920,473
- Adam L Halberstadt$2,627,327
- Fabrisia Ambrosio$15,553,662
Others in their field
Top investigators on “Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$608,226,434
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$177,347,135
- John M Lachin · George Washington University$155,262,668
- David M Nathan · Massachusetts Institute Of Technology$142,806,023
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Jose A Luchsinger · Columbia University Health Sciences$75,551,718
Research focus
Diabetes MellitusBeta CellAdultCell ProliferationInsulinStructure Of Beta Cell Of IsletNon-Insulin-Dependent Diabetes MellitusNatural RegenerationSafetyInsulin-Dependent Diabetes MellitusLeadIn VivoNational Institute Of Diabetes And Digestive And Kidney DiseasesSmall MoleculeFamilyCell CycleRodentPathway InteractionsPharmaceutical PreparationsPhosphotransferasesAffectParathyroid Hormone Related ProteinIsletUnited States National Institutes Of Health
Grant awards (106)
DREAM Complex Maintenance of Human Beta Cell Quiescence$614,378
R01 · FY2025 · DK · contact PI
DYRK Inhibitors for Human Beta Cell Expansion$689,139
R01 · FY2024 · DK · contact PI
DREAM Complex Maintenance of Human Beta Cell Quiescence$589,802
R01 · FY2024 · DK · contact PI
DYRK Inhibitors for Human Beta Cell Expansion$717,853
R01 · FY2023 · DK · contact PI
Biological and Medicinal Chemistry Approaches to Human Beta Cell Regeneration$629,942
R01 · FY2023 · DK · contact PI
DREAM Complex Maintenance of Human Beta Cell Quiescence$614,378
R01 · FY2023 · DK · contact PI
Phase 1 Translational Diabetes Research Using The DYRK1A inhibitor, Harmine$338,000
R01 · FY2023 · DK · contact PI
DYRK Inhibitors for Human Beta Cell Expansion$717,853
R01 · FY2022 · DK · contact PI
Novel Selective Type II kinase Inhibitors to treat Diabetes$674,446
R01 · FY2022 · DK
Epigenetic Control of Human Beta Cell Proliferation$631,930
R01 · FY2022 · DK · contact PI
Biological and Medicinal Chemistry Approaches to Human Beta Cell Regeneration$629,942
R01 · FY2022 · DK · contact PI
DREAM Complex Maintenance of Human Beta Cell Quiescence$614,378
R01 · FY2022 · DK · contact PI
Phase 1 Translational Diabetes Research Using The DYRK1A inhibitor, Harmine$338,000
R01 · FY2022 · DK · contact PI
DYRK Inhibitors for Human Beta Cell Expansion$718,915
R01 · FY2021 · DK · contact PI
Novel Selective Type II kinase Inhibitors to treat Diabetes$674,446
R01 · FY2021 · DK
Epigenetic Control of Human Beta Cell Proliferation$631,930
R01 · FY2021 · DK · contact PI
Biological and Medicinal Chemistry Approaches to Human Beta Cell Regeneration$629,942
R01 · FY2021 · DK · contact PI
DREAM Complex Maintenance of Human Beta Cell Quiescence$615,287
R01 · FY2021 · DK · contact PI
Novel Selective Type II kinase Inhibitors to treat Diabetes$674,446
R01 · FY2020 · DK
Epigenetic Control of Human Beta Cell Proliferation$631,930
R01 · FY2020 · DK · contact PI
Biological and Medicinal Chemistry Approaches to Human Beta Cell Regeneration$629,942
R01 · FY2020 · DK · contact PI
Novel Selective Type II kinase Inhibitors to treat Diabetes$674,446
R01 · FY2019 · DK
Epigenetic Control of Human Beta Cell Proliferation$631,930
R01 · FY2019 · DK · contact PI
Dyrk Inhibitors for Human Beta Cell Expansion$500,283
R01 · FY2019 · DK · contact PI
Novel Selective Type II kinase Inhibitors to treat Diabetes$419,648
R01 · FY2019 · DK
Novel Selective Type II kinase Inhibitors to treat Diabetes$674,446
R01 · FY2018 · DK
Epigenetic Control of Human Beta Cell Proliferation$631,930
R01 · FY2018 · DK · contact PI
Dyrk Inhibitors for Human Beta Cell Expansion$500,283
R01 · FY2018 · DK · contact PI
Dyrk Inhibitors for Human Beta Cell Expansion$561,169
R01 · FY2017 · DK · contact PI
Dyrk Inhibitors for Human Beta Cell Expansion$500,283
R01 · FY2016 · DK · contact PI
Dyrk Inhibitors for Human Beta Cell Expansion$40,592
R01 · FY2016 · DK · contact PI
Pancreatic Islet Growth Factors: Transgenic and Viral Modeling$368,663
R01 · FY2015 · DK · contact PI
Molecular Mechanisms of Physiologic Beta Cell Growth in Juvenile Human Pancreas$163,876
UC4 · FY2015 · DK
Molecular Mechanisms of Physiologic Beta Cell Growth in Juvenile Human Pancreas$2,468,076
UC4 · FY2014 · DK
Molecular Mechanisms of Physiologic Beta Cell Growth in Juvenile Human Pancreas$1,329,213
UC4 · FY2014 · DK
Pancreatic Islet Growth Factors: Transgenic and Viral Modeling$368,663
R01 · FY2014 · DK · contact PI
Multi-Disciplinary Approaches to Driving Therapeutic Human Beta Cell Replication$100,000
U01 · FY2014 · DK · contact PI
Multi-Disciplinary Approaches to Driving Therapeutic Human Beta Cell Replication$920,686
U01 · FY2013 · DK · contact PI
Pancreatic Islet Growth Factors: Transgenic and Viral Modeling$336,221
R01 · FY2013 · DK · contact PI
Multi-Disciplinary Approaches to Driving Therapeutic Human Beta Cell Replication$711,622
U01 · FY2012 · DK · contact PI
Pathophysiology of PTH-related Protein (1-36) in Humans$395,906
R01 · FY2012 · DK · contact PI
Pancreatic Islet Growth Factors: Transgenic and Viral Modeling$232,313
R01 · FY2012 · DK · contact PI
Multi-Disciplinary Approaches to Driving Therapeutic Human Beta Cell Replication$159,888
U01 · FY2012 · DK · contact PI
Islet Growth Factors: Transgenic and Viral Modeling$120,885
R01 · FY2012 · DK · contact PI
Multi-Disciplinary Approaches to Driving Therapeutic Human Beta Cell Replication$871,512
U01 · FY2011 · DK · contact PI
Pathophysiology of PTH-related Protein (1-36) in Humans$617,305
R01 · FY2011 · DK · contact PI
Research Training in Diabetes and Endocrinology$192,157
T32 · FY2011 · DK · contact PI
Pathophysiology of PTH-related Protein (1-36) in Humans$903,687
R01 · FY2010 · DK · contact PI
Multi-Disciplinary Approaches to Driving Therapeutic Human Beta Cell Replication$871,510
U01 · FY2010 · DK · contact PI
Islet Growth Factors Transgenic and Viral Modeling$278,134
R01 · FY2010 · DK · contact PI
Research Training in Diabetes and Endocrinology$252,093
T32 · FY2010 · DK · contact PI
Pathophysiology of PTH-related Protein (1-36) in Humans$34,084
R01 · FY2010 · DK · contact PI
Modeling Bone Formation and 1,25 Vitamin D in Humoral Hypercalcemia of Malignancy$289,685
R01 · FY2009 · DK · contact PI
Islet Growth Factors Transgenic and Viral Modeling$281,256
R01 · FY2009 · DK · contact PI
Research Training in Diabetes and Endocrinology$178,741
T32 · FY2009 · DK · contact PI
Research Training in Diabetes and Endocrinology$47,895
T32 · FY2009 · DK · contact PI
MODELING BONE FORMATION & 1,25 VITAMIN D IN HUMORAL HYPERCALCEMIA OF MALIGNANCY$289,685
R01 · FY2008 · DK · contact PI
Islet Growth Factors Transgenic and Viral Modeling$281,559
R01 · FY2008 · DK · contact PI
Research Training in Diabetes and Endocrinology$144,057
T32 · FY2008 · DK · contact PI
Research Training in Diabetes and Endocrinology$61,557
T32 · FY2008 · DK · contact PI
Pathophysiology of PTH-related Protein (1-36) in Humans$458,583
R01 · FY2007 · DK · contact PI
MODELING BONE FORMATION & 1,25 VITAMIN D IN HUMORAL HYPERCALCEMIA OF MALIGNANCY$295,597
R01 · FY2007 · DK · contact PI
Islet Growth Factors Transgenic and Viral Modeling$287,606
R01 · FY2007 · DK · contact PI
Research Training in Diabetes and Endocrinology$223,074
T32 · FY2007 · DK · contact PI
Research Training in Diabetes and Endocrinology$59,198
T32 · FY2007 · DK · contact PI
Pathophysiology of PTH-related Protein (1-36) in Humans$458,525
R01 · FY2006 · DK · contact PI
Islet Growth Factors Transgenic and Viral Modeling$296,497
R01 · FY2006 · DK · contact PI
MODELING BONE FORMATION AND 125 VITAMIN D IN HUMORAL HYPERCALCEMIA OF MALIGNANCY$292,494
R01 · FY2006 · DK · contact PI
Research Training in Diabetes and Endocrinology$161,345
T32 · FY2006 · DK · contact PI
Research Training in Diabetes and Endocrinology$57,189
T32 · FY2006 · DK · contact PI
Islet Allograft Gene Therapy for Primate Diabetes$593,120
R33 · FY2005 · DK
Pathophysiology of PTH-related Protein (1-36) in Humans$455,880
R01 · FY2005 · DK
Research Training in Diabetes and Endocrinology$236,237
T32 · FY2005 · DK
Islet Allograft Gene Therapy for Primate Diabetes$593,120
R33 · FY2004 · DK
Pathophysiology of PTH-related Protein (1-36) in Humans$442,975
R01 · FY2004 · DK
RESEARCH TRAINING IN DIABETES AND ENDOCRINOLOGY$216,686
T32 · FY2004 · DK
Renal Calcium Handling &1, 25 Vitamin D Synthesis$56,217
M01 · FY2004 · RR
Anabolic Skeletal Agents for Osteoporosis$35,000
R13 · FY2004 · DK
Islet Allograft Gene Therapy for Primate Diabetes$606,059
R33 · FY2003 · DK
Pathophysiology of PTH-related Protein (1-36) in Humans$431,518
R01 · FY2003 · DK
RESEARCH TRAINING IN DIABETES AND ENDOCRINOLOGY$224,151
T32 · FY2003 · DK
Pathophysiology of PTH-related Protein (1-36) in Humans$393,922
R01 · FY2002 · DK
PTH-RELATED PROTEIN IN THE PANCREATIC ISLET$269,961
R01 · FY2002 · DK
PTH RELATED PROTEIN--NUCLEAR TARGETING AND MITOGENESIS$254,345
R01 · FY2002 · DK
RESEARCH TRAINING IN DIABETES AND ENDOCRINOLOGY$184,200
T32 · FY2002 · DK
1,25 VITAMIN D SYNTHESIS IN RESPONSE TO PTH &PTHR$0
M01 · FY2002 · RR
1,25 VITAMIN D SYNTHESIS IN RESPONSE TO PTH &PTHR$0
M01 · FY2002 · RR
SECRETION OF PARATHYROID HORMONE AND PTHRP$0
M01 · FY2002 · RR
SECRETION OF PARATHYROID HORMONE AND PTHRP$0
M01 · FY2002 · RR
1,25 VITAMIN D SYNTHESIS--PTHRP IN MALIGN HYPERCALCEMIA$0
M01 · FY2002 · RR
1,25 VITAMIN D SYNTHESIS--PTHRP IN MALIGN HYPERCALCEMIA$0
M01 · FY2002 · RR
Pathophysiology of PTH-related Protein (1-36) in Humans$384,525
R01 · FY2001 · DK
ISLET GROWTH FACTORS--TRANSGENIC AND VIRAL MODELING$309,603
R01 · FY2001 · DK
PTH-RELATED PROTEIN IN THE PANCREATIC ISLET$264,438
R01 · FY2001 · DK
PTH RELATED PROTEIN--NUCLEAR TARGETING AND MITOGENESIS$248,608
R01 · FY2001 · DK
RESEARCH TRAINING IN DIABETES AND ENDOCRINOLOGY$172,359
T32 · FY2001 · DK
1,25 VITAMIN D SYNTHESIS IN RESPONSE TO PTH &PTHR$0
M01 · FY2001 · RR
SECRETION OF PARATHYROID HORMONE AND PTHRP$0
M01 · FY2001 · RR
1,25 VITAMIN D SYNTHESIS--PTHRP IN MALIGN HYPERCALCEMIA$0
M01 · FY2001 · RR
ISLET GROWTH FACTORS--TRANSGENIC AND VIRAL MODELING$301,997
R01 · FY2000 · DK
PTH-RELATED PROTEIN IN THE PANCREATIC ISLET$258,033
R01 · FY2000 · DK
PTH RELATED PROTEIN--NUCLEAR TARGETING AND MITOGENESIS$243,038
R01 · FY2000 · DK
RESEARCH TRAINING IN DIABETES AND ENDOCRINOLOGY$180,200
T32 · FY2000 · DK
1,25 VITAMIN D SYNTHESIS IN RESPONSE TO PTH &PTHR$0
M01 · FY2000 · RR
SECRETION OF PARATHYROID HORMONE AND PTHRP$0
M01 · FY2000 · RR
1,25 VITAMIN D SYNTHESIS--PTHRP IN MALIGN HYPERCALCEMIA$0
M01 · FY2000 · RR